In the first three quarters of 2023, BY-HEALTH achieved a revenue of RMB 7.82 billion yuan (USD $1.09 billion), representing a year-on-year growth of 26.34%. The net profit reached RMB 1.901 billion yuan (USD $270 million), showing a year-on-year increase of 28.28%. The company maintained its leading position in the offline sales channel market. Protein powder and probiotics saw a year-on-year growth of 30.7% and 9.7% from January to August.
CSPC Innovation
In the first three quarters of 2023, CSPC Innovation achieved a revenue of RMB 1.9 billion yuan (USD $270 million), representing a year-on-year growth of 0.46%. The net profit reached RMB 583 million yuan (USD $81 million), showing a year-on-year increase of 12.74%. Functional raw materials accounted for approximately 85.98% of the core business, mainly consisting of caffeine and acarbose. Health food products made up about 14.02% of the core business, primarily consisting of vitamin C chewable tablets.
Minsheng Healthcare
In the first three quarters of 2023, Minsheng Healthcare achieved a revenue of RMB 486 million yuan (USD $68 million), with a year-on-year growth of 6.7%. The net profit was RMB 81.7 million yuan (USD $11.4 million), showing a year-on-year increase of 9.12%. Out of the total fundraising of RMB 465 million yuan (USD $65 million) from this IPO, approximately 71% of the funds will be allocated to the intelligent production line technology improvement project for health food. The remaining 20% and 9% will be invested in the technology improvement project for the production line of mineral OTC products and the technology improvement project respectively. (Source:
shukangzhengxun)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE
(Source: shukangzhengxun)